 |
|
Longitudinal Neuropsychological and Genetic Linkage Analysis of Persons at Risk for Huntington's Disease
Bruno Giordani, PhD;
Stanley Berent, PhD;
Michael J. Boivin, PhD;
John B. Penney, MD;
Shirley Lehtinen, MA;
Dorene S. Markel, MS, MHSA;
Zane Hollingsworth, MPH;
Grant Butterbaugh, PhD;
Richard D. Hichwa, PhD;
James F. Gusella, PhD;
Anne B. Young, MD, PhD
Arch Neurol. 1995;52(1):59-64.
Abstract
| |
Objective
To determine (1) whether the neuropsychological profiles of healthy individuals at risk (AR) for Huntington's disease who were positive (AR/+) or negative (AR/—) for the Huntington's disease genetic marker differed from those of symptomatic patients with Huntington's disease and normal control individuals and (2) whether the neuropsychological performance of the two AR groups differed from each other on three assessments during a 4-year span.
Design
Case-control, double-blind study, with AR status determined by genetic linkage analysis (G8 probe), in addition to examination of trinucleotide repeats for most AR subjects.
Setting
The Neuropsychology Program in the Department of Psychiatry and the Department of Neurology at the University of Michigan Medical Center, Ann Arbor, a tertiary care center.
Participants
Eight subjects matched as closely as possible forage, gender, and education in each of the following groups: AR/+, AR/—, normal control, and Huntington's disease.
Measures
A battery of neuropsychological tasks, including measures of intelligence, memory, problem solving, and motor ability.
Results
Although both AR groups demonstrated variability on select intellectual subtests relative to normal subjects, they did not differ from each other on the three assessments during a 4-year span. Patients with Huntington's disease performed more poorly than the other groups across a range of neuropsychological measures.
Conclusions
These results do not support previous evaluations concluding that AR/+ individuals demonstrate cognitive impairments as compared with AR/- individuals. Findings in earlier studies without genetic linkage analysis of lower performance of AR individuals, including children, as compared with normal controls may relate to extraneous environmental and familial issues that interfere with intellectual development.
Author Affiliations
From the Departments of Psychiatry (Drs Giordani, Berent, and Boivin), Psychology (Drs Giordani and Berent and Ms Lehtinen), and Neurology (Dr Berent) and Human Genome Center (Ms Markel), University of Michigan, Ann Arbor; Department of Psychology, Spring Arbor (Mich) College (Dr Boivin); Neurology Department and Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Penney, Gusella, and Young and Mr Hollingsworth); Department of Psychology, Children's Hospital, New Orleans, La (Dr Butterbaugh); and Department of Radiology, University of Iowa, Iowa City (Dr Hichwa).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Functional compensation of motor function in pre-symptomatic Huntington's disease
Kloppel et al.
Brain 2009;132:1624-1632.
ABSTRACT
| FULL TEXT
Longitudinal Evaluation of "Presymptomatic" Carriers of Huntington's Disease
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:310-317.
ABSTRACT
| FULL TEXT
Preparing for preventive clinical trials: the Predict-HD study.
Paulsen et al.
Arch Neurol 2006;63:883-890.
ABSTRACT
| FULL TEXT
Huntington's Disease: Phenomenological Diversity of a Neuropsychiatric Condition That Challenges Traditional Concepts in Neurology and Psychiatry
Tost et al.
Am. J. Psychiatry 2004;161:28-34.
FULL TEXT
Cognitive and Motor Functioning in Gene Carriers for Huntington's Disease: A Baseline Study
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:7-16.
ABSTRACT
| FULL TEXT
Behavioural complaints in participants who underwent predictive testing for Huntington's disease
Witjes-Ane et al.
J. Med. Genet. 2002;39:857-862.
FULL TEXT
Clinical markers of early disease in persons near onset of Huntington's disease
Paulsen et al.
Neurology 2001;57:658-662.
ABSTRACT
| FULL TEXT
Effects of Depression on Working Memory in Presymptomatic Huntington's Disease
Nehl et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:342-346.
ABSTRACT
| FULL TEXT
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood et al.
Arch Neurol 2001;58:273-278.
ABSTRACT
| FULL TEXT
Subtle changes among presymptomatic carriers of the Huntington's disease gene
Kirkwood et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:773-779.
ABSTRACT
| FULL TEXT
Confirmation of Subtle Motor Changes Among Presymptomatic Carriers of the Huntington Disease Gene
Kirkwood et al.
Arch Neurol 2000;57:1040-1044.
ABSTRACT
| FULL TEXT
The genetic basis of cognition
Flint
Brain 1999;122:2015-2032.
ABSTRACT
| FULL TEXT
Longitudinal Cognitive and Motor Changes Among Presymptomatic Huntington Disease Gene Carriers
Kirkwood et al.
Arch Neurol 1999;56:563-568.
ABSTRACT
| FULL TEXT
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers
Hahn-Barma et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:172-177.
ABSTRACT
| FULL TEXT
Early Cognitive and Motor Symptoms in Identified Carriers of the Gene for Huntington Disease
de Boo et al.
Arch Neurol 1997;54:1353-1357.
ABSTRACT
Cognitive Manifestations of Huntington Disease in Relation to Genetic Structure and Clinical Onset
Jason et al.
Arch Neurol 1997;54:1081-1088.
ABSTRACT
|
